Company Overview - American Healthcare REIT (AHR) has seen a significant increase in its stock price, rising 79.6% over the past year and 10.3% year-to-date, with a current dividend yield of 1.92% [1] - AHR went public in February 2024 at $12 per share, with a market capitalization of approximately $1.5 billion and total assets valued at $4.6 billion [1] Market Position - The demand for senior housing is increasing as the baby boomer population ages, while the supply of such housing remains stagnant [1] - AHR's RIDEA structure allows it to participate directly in the operating profits of its properties, which is a higher-risk, higher-reward model compared to traditional REITs [1] Industry Trends - The healthcare sector is experiencing stable growth, and REITs are benefiting from a favorable interest rate environment [1] - Staffing shortages in nursing homes and hospitals are a growing concern, which could further drive demand for AHR's services [1] Future Outlook - AHR is expected to have a strong performance in 2026 as it pays down debt and builds cash reserves, which can be returned to shareholders in the form of dividends [1] - The requirement for REITs to distribute over 90% of their profits to shareholders positions AHR for potential strong yields alongside capital gains [1]

Core Insights - Welltower Inc. is a leading healthcare real estate investment trust (REIT) with a market cap of $146.6 billion, focusing on properties serving the healthcare industry in the U.S., Canada, and the U.K. [1] - The company benefits from long-term demographic trends, including aging populations and increasing demand for healthcare services, by partnering with top healthcare systems and operators [2] Company Performance - Welltower's stock reached a 52-week high of $216.43 on February 17 and is currently trading 3.9% below that peak, with shares having increased by 3% over the past three months [3] - Over the past six months, Welltower's stock has risen by 24.2% and by 32.6% over the past 52 weeks, significantly outperforming the Real Estate Select Sector SPDR Fund (XLRE), which saw a 5.4% increase during the same period [4] - The stock has consistently traded above its 200-day moving average over the past year, indicating a bullish trend [4] Financial Highlights - In Q4 FY2025, Welltower reported revenue of approximately $3.18 billion and normalized funds from operations of $1.45 per share, showing strong year-over-year growth [5] - The company's same-store revenue in its senior housing operating portfolio increased by 9.6%, with occupancy rising by about 400 basis points [5] - Welltower completed $13.9 billion in investments and $7.5 billion in dispositions and loan repayments during the quarter, reflecting active portfolio repositioning [5]

Core Insights - American Healthcare REIT (AHR) reported strong financial performance with double-digit same-store NOI growth for the second consecutive year, achieving 11.8% in Q4 and 14.2% for the full year 2025 [3][6][15] - The company is focused on acquisitions and development, investing over $950 million in 2025, primarily in the SHOP segment, and has a dynamic pipeline with more than $230 million in awarded deals [5][12][10] - AHR issued 2026 guidance for NFFO of $1.99 to $2.05 per share and same-store NOI growth of 7% to 11%, indicating continued growth potential [4][17] Financial Performance - AHR's normalized FFO attributable to common stockholders was $0.46 per diluted share for Q4 2025 and $1.72 per diluted share for the full year, reflecting a 22% year-over-year growth [15] - The company improved its debt-to-EBITDA ratio to 3.4x, indicating a stronger balance sheet position [4][17] Operational Highlights - The operating portfolio, including Trilogy and SHOP, now contributes 76.9% of consolidated cash NOI, with Trilogy achieving a same-store NOI increase of 14% in Q4 and 18.4% for 2025 [6][7] - The SHOP segment showed the strongest growth, with same-store NOI up 24.6% in Q4 and 25.2% for 2025, supported by disciplined rate management and rising occupancy [8][10] Leadership and Strategy - Interim CEO Jeff Hanson emphasized continuity in strategy during CEO Danny Prosky's medical leave, with no changes to investment and capital allocation approaches [2][4] - The company continues to focus on higher-acuity assisted living and memory care assets, with a "know the operator first" approach to acquisitions [10][13] Market Conditions - Industry data indicates that new construction and supply growth remain historically low, with deliveries below 1% of existing inventory, while demand is driven by the aging baby boomer population [11][13] - AHR's management noted that many SHOP assets acquired in 2025 will not be included in the same-store pool for 2026, which may affect same-store metrics despite contributing to overall results [18]

Core Insights - Ventas, Inc. (NYSE:VTR) is recognized as one of the 14 best real estate stocks to buy according to hedge funds [1] - Morgan Stanley raised its price target for Ventas to $90 from $80, maintaining an Equal Weight rating, citing strong quarterly performance and expectations for further growth in 2026 [2] - The company's Q4 2025 earnings call highlighted a standout year, driven by its 1-2-3 Strategy focused on senior housing, with strong demand and limited new supply [3] Financial Performance - Normalized FFO per share increased by 9% for the year, while same-store SHOP cash NOI rose by 15%, indicating robust performance in the senior housing sector [4] - Total shareholder returns for Ventas reached 35% in 2025, outperforming industry benchmarks and the broader S&P 500 [4] Company Overview - Ventas, Inc. is a healthcare-focused REIT with a diversified portfolio, owning approximately 1,400 properties across North America and the United Kingdom, including senior housing communities and various healthcare facilities [5]

Financial Data and Key Metrics Changes - For Q4 2025, normalized FFO increased by 42.7% over the prior quarter to $104.1 million, while normalized FAD increased by 38.7% to $103 million [15] - On a per-share basis, normalized FFO increased by $0.07, or 17.5%, to $0.47 per share, and normalized FAD increased by $0.05, or 12.2%, to $0.46 per share [15] - For the full year, normalized FFO per share increased by $0.26, or 17.3%, to $1.76 per share, and normalized FAD increased by $0.22, or 14.3%, to $1.76 per share [15] Business Line Data and Key Metrics Changes - In Q4, the company completed approximately $562 million of investments, including its first SHOP deal, which involved three communities in Texas totaling 270 assisted living and memory care units [11] - The blended stabilized yield on Q4 investments was 8.8% [11] - Since year-end, the company has closed on approximately $215 million of investments, including six skilled nursing facilities and two care homes in the UK [12] Market Data and Key Metrics Changes - The investment pipeline remains strong at approximately $500 million, with about half in UK care homes, a third in skilled nursing, and the remainder in a combination of SHOP deals and loans [12][35] - The skilled nursing operating environment is stable and largely supportive across most states, with the senior housing environment in both the U.S. and U.K. also stable and gaining strength [8] Company Strategy and Development Direction - The company aims to be a unique healthcare REIT focused on disciplined investments in assets and operators that can significantly impact senior housing and care [10] - The company has doubled its team and added capabilities in areas like tax and data science to support long-term growth [6] - The strategic push into the UK care home market and the SHOP segment is seen as a significant growth opportunity [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the skilled nursing environment, noting improvements in labor conditions and regulatory frameworks [25] - The company anticipates a substantial year of external growth, supported by a strong balance sheet and access to capital [9][19] - Initial guidance for fiscal year 2026 indicates normalized FFO per share of $1.90-$1.95, representing a year-over-year increase of 9.4% [17] Other Important Information - The company sold 6.5 million shares on a forward basis at an average price of $37.30, generating gross proceeds of approximately $242.5 million [16] - The company maintains low leverage with net debt to EBITDA of 0.7 times and a fixed charge coverage ratio of 10.5 times [19] Q&A Session Summary Question: Guidance and expectations for the pipeline going forward - Management indicated that they are seeing consistent inbound interest in SHOP deals and are open to both large and small opportunities [22][23] Question: Sustainability of coverage levels in skilled nursing facilities - Management believes the skilled nursing environment is strong, with operators eager to grow and occupancy levels providing room for improvement [25][26] Question: Focus of data analytic hires - The data science team is primarily focused on enhancing SHOP capabilities but will impact the entire organization [31] Question: Details on the investment pipeline - The pipeline consists of approximately half UK care homes, a third US skilled nursing, and the remainder in SHOP and loans [35] Question: Competitive landscape in property types - SHOP is noted as the most competitive segment, with significant capital pursuing deals [36] Question: Future funding strategies - Management plans to balance between equity issuances and utilizing balance sheet capacity as opportunities arise [60][61] Question: Underwriting criteria within SHOP - The company continues to seek low double-digit IRR and evaluates each deal's path to achieving that, despite cap rate compression [59]

Core Viewpoint - Ventas, Inc. is a leading real estate investment trust (REIT) focusing on senior housing and healthcare properties, with a diverse portfolio that includes senior housing communities, medical office buildings, and hospitals [1] Group 1: Financial Performance - Ventas reported an "outstanding year" in 2025, driven by its senior housing segment, with a 9% increase in normalized funds from operations (FFO) per share and a 15% growth in same-store SHOP cash net operating income (NOI) [3] - The company's enterprise value exceeded $50 billion, with fourth-quarter annualized NOI and SHOP NOI reaching $2.5 billion and $1.3 billion, respectively [4] Group 2: Market Position and Strategy - Ventas competes with other REITs like Welltower and Healthpeak Properties in the healthcare real estate sector [1] - The company employs a "1, 2, 3 strategy" focusing on senior housing growth, value-creating investments, and portfolio cash flow, which has contributed to its financial success [3] Group 3: Stock Performance and Analyst Insights - On February 10, 2026, RBC Capital set a new price target of $91 for VTR, suggesting a potential increase of about 9.92% from its trading price of $82.79 at that time [2] - The stock's current price is $82.87, showing a slight increase of 0.15% from the previous day, with fluctuations between $82.67 and $83.14 during the trading day [2] Group 4: Future Outlook - Ventas has increased its quarterly dividend and expects continued growth in 2026, led by its Senior Housing Operating Portfolio (SHOP) [4]

Financial Data and Key Metrics Changes - In 2025, normalized FFO per share increased by 9%, with same-store SHOP cash net operating income growing by 15%, marking the fourth consecutive year of double-digit SHOP NOI growth [5][26] - The enterprise value exceeded $50 billion, with fourth quarter annualized NOI and SHOP NOI reaching $2.5 billion and $1.3 billion, respectively [5][26] - Total shareholder returns for 2025 were 35%, significantly outperforming industry benchmarks and the S&P 500 [6] Business Line Data and Key Metrics Changes - The SHOP same-store portfolio saw revenue growth of over 8%, driven by a 300 basis points year-over-year occupancy increase [12] - NOI for SHOP grew by 15.4% year-over-year in the fourth quarter, with margins increasing by 180 basis points to over 28% [13] - The Outpatient Medical and Research (OMR) business grew same-store cash NOI by nearly 4% year-over-year in the fourth quarter [26] Market Data and Key Metrics Changes - The over 80 population is projected to grow by 28% in the next five years, with over 2 million people turning 80 in 2026 [6][8] - New supply of senior housing remains constrained, with only about 2,500 new units started in the fourth quarter of 2025 [8] Company Strategy and Development Direction - The company aims to capitalize on the significant value creation opportunity in senior housing through its 1, 2, 3 strategy, focusing on organic growth, value-creating investments, and driving cash flow [4][9] - The company plans to continue aggressive investment in senior housing, targeting $2.5 billion in acquisitions for 2026 [10][22] - The Ventas Operational Insights Platform is a key competitive advantage, enhancing operational performance and analytics capabilities [19][20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the multi-year NOI growth and value creation opportunities ahead, driven by strong demand trends in senior housing [6][9] - The company expects to deliver high single-digit growth in normalized FFO per share in 2026, with SHOP producing its fifth consecutive year of double-digit same-store cash NOI growth [10][29] - Management highlighted the importance of maintaining strong relationships with operators and enhancing engagement to drive performance [20] Other Important Information - The board approved an 8% increase in the quarterly dividend, reflecting strong performance and a positive multi-year outlook [11] - The company raised over $7 billion in capital during 2025, including nearly $4 billion in bank, bonds, and mortgage debt [27] Q&A Session Summary Question: On the Brookdale reset on the triple net side - Management indicated that a reasonable assumption for the triple net business would be around 3% on average for escalators, with the January Brookdale increases being an outlier [33] Question: Guidance on share count for 2026 - Management did not provide a specific year-end share count but noted that the $2.5 billion of investments would be principally funded with equity [34] Question: Acquisition guidance and market competition - Management confirmed a very active pipeline and noted that half of the $800 million closed was off-market, despite increased competition in marketed deals [38][40] Question: Impact of flu season on occupancy - Management reported minimal flu impacts and highlighted improved infection control measures since the pandemic [42][43] Question: Future growth opportunities in underperforming markets - Management acknowledged ongoing pruning within the portfolio and noted that some senior housing assets may be disposition candidates [50] Question: Brookdale transitions and immediate growth drivers - Management highlighted the advantages of the transitioned Brookdale communities and expected modest growth in 2026, with significant potential ramp-up in 2027 [55] Question: Supply concerns in senior housing - Management emphasized that the demand from the aging population would likely overwhelm any new supply, projecting a long runway for growth [94][95] Question: Affordability of senior housing products - Management reiterated that the senior housing product provides valuable benefits at an affordable cost, especially for the wealthiest generation of baby boomers [98][99]

Core Insights - StepStone Real Estate (SRE) and Blue Moon Capital Partners have completed a $250 million continuation vehicle to operate five Class A stabilized senior housing communities [1] - The partnership aims to acquire additional high-quality senior housing communities and enhance their existing portfolio [1][2] Company Overview - StepStone Group is a global private markets investment firm managing approximately $771 billion in total capital, with $209 billion in assets under management as of September 30, 2025 [3] - Blue Moon Capital Partners focuses exclusively on senior housing, investing in Independent Living, Assisted Living, and Memory Care sectors [4] Strategic Focus - SRE is committed to building its senior housing exposure by partnering with experienced operators like Blue Moon across the US and Europe [2] - The collaboration emphasizes incorporating technology into operations and advancing workforce culture to maintain market leadership in senior housing [2][3] Growth Potential - Blue Moon aims to capitalize on the expected dramatic growth in resident demand for senior housing over the next two decades [4]

Company Overview - Ventas, Inc. (NYSE: VTR) is an S&P 500 company focused on creating exceptional environments for a growing aging population [4] - The company operates approximately 1,400 properties in North America and the United Kingdom, playing a vital role in the longevity economy [4] - Ventas's portfolio includes over 850 senior housing communities, outpatient medical buildings, research centers, and healthcare facilities [4] Growth Strategy - The company's growth is driven by its senior housing communities, which provide essential services to residents [4] - Ventas aims to achieve superior performance by leveraging operational expertise, data-driven insights from its Ventas OI™ platform, and strong financial relationships [4] - The commitment of Ventas's seasoned team is to help people live longer, healthier, and happier lives [4] Upcoming Earnings Release - Ventas will release its fourth quarter 2025 earnings after the close of trading on February 5, 2026 [1] - A conference call to discuss the earnings will take place on February 6, 2026, at 10:00 a.m. Eastern Time [1]

Core Insights - Healthpeak Properties, Inc. (DOC) is a publicly traded real estate investment trust (REIT) with a market cap of $11.6 billion, focusing on a diversified portfolio of healthcare properties [1][2] Company Overview - DOC is classified as a large-cap stock, emphasizing its significant size and influence in the healthcare REIT sector [2] - The company specializes in high-quality healthcare assets that benefit from long-term leases and stable cash flows [2] Stock Performance - DOC's stock has decreased by 21.9% from its 52-week high of $21.28, reached on March 10, and has underperformed the Dow Jones Industrial Average (DOWI) [3][4] - Over the past three months, DOC shares have declined by 8.1%, while DOWI has risen by 5.7% [3] - In the last 52 weeks, DOC has fallen by 20.6%, compared to DOWI's increase of 10.4% [4] - The stock has been trading below its 200-day moving average since late October and has recently dipped below its 50-day moving average [4] Financial Performance - In the third quarter, Healthpeak reported total revenue of approximately $705.9 million, slightly exceeding expectations, supported by stable outpatient medical and lab leasing activity [5] - The company generated Nareit FFO of about $0.45 per share and Adjusted FFO of $0.46, aligning with guidance [5] - Healthpeak recorded a net loss of roughly $0.17 per share, primarily due to equity losses from unconsolidated ventures, which affected diluted EPS [5] - Occupancy trends were mixed, with rising outpatient medical demand but pressure on lab occupancy [5] Competitive Position - Healthpeak's underperformance is notable when compared to its competitor, Omega Healthcare Investors, Inc. (OHI), which has seen a 13.3% rise over the past 52 weeks and an 18.8% increase over the past six months [6]